RxSight Inc [RXST] stock is trading at $31.91, up 3.04%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RXST shares have gain 6.08% over the last week, with a monthly amount drifted -14.22%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
RxSight Inc [NASDAQ: RXST] stock has seen the most recent analyst activity on December 20, 2024, when Stifel downgraded its rating to a Hold and also revised its price target to $40 from $65. Previously, Wells Fargo downgraded its rating to Equal Weight on December 11, 2024, and dropped its price target to $42. On December 06, 2024, UBS initiated with a Buy rating and assigned a price target of $52 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $72 on October 29, 2024. Needham reiterated its recommendation of a Buy and raised its price target to $66 on August 20, 2024. Needham reiterated a Buy rating for this stock on August 06, 2024, and downed its price target to $54. In a note dated May 07, 2024, BTIG Research reiterated an Buy rating on this stock and boosted its target price from $61 to $72.
RxSight Inc [RXST] stock has fluctuated between $26.29 and $66.54 over the past year. Currently, Wall Street analysts expect the stock to reach $70.14 within the next 12 months. RxSight Inc [NASDAQ: RXST] shares were valued at $31.91 at the most recent close of the market. An investor can expect a potential return of 119.81% based on the average RXST price forecast.
Analyzing the RXST fundamentals
RxSight Inc [NASDAQ:RXST] reported sales of 128.29M for the trailing twelve months, which represents a growth of 59.08%. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at -0.28%, Pretax Profit Margin comes in at -0.22%, and Net Profit Margin reading is -0.22%. To continue investigating profitability, this company’s Return on Assets is posted at -0.1, Equity is -0.14 and Total Capital is -0.14. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 30.75 points at the first support level, and at 29.58 for the second support level. However, for the 1st resistance point, the stock is sitting at 32.72, and for the 2nd resistance point, it is at 33.52.
Ratios To Look Out For
For context, RxSight Inc’s Current Ratio is 12.67. In addition, the Quick Ratio stands at 11.71 and the Cash Ratio stands at 0.74. Considering the valuation of this stock, the price to sales ratio is 10.03, the price to book ratio is 4.63.
Transactions by insiders
Recent insider trading involved Maniar Shweta, Director, that happened on Jan 22 ’25 when 3519.0 shares were purchased. Director, Corley Jesse Anderson completed a deal on Jan 16 ’25 to buy 1767.0 shares. Meanwhile, Director Corley Jesse Anderson bought 1443.0 shares on Jan 15 ’25.
